Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer

University of Manitoba

$65,000.00

HER2+ breast-to-brain metastasis and TME co-evolve in therapeutic resistance and recurrence

EF 2023-24

Résumé
No successful treatments exist for women with breast cancer that have high levels of the growth factor receptor HER2 and have developed tumors that spread to the brain. This team has developed a mouse model to study breast cancer in the brain. They found a drug that eliminates the visible tumor in the mouse brain, but the tumor eventually grows back. The team will study the changes in the second tumor that show a marker protein that is not seen in the first breast cancer brain tumor. They will test if deleting this marker will restore sensitivity to treatment. They study how the brain tissue supports the breast tumor growth in brain and which signals of the breast cancer cells lead to a tumor friendly environment in the brain. These data will guide better treatment strategies in the future.
Programme
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
517000
Name
Hombach-Klonisch Sabine
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
HER2+ breast-to-brain metastasis and TME co-evolve in therapeutic resistance and recurrence
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$65,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Keyworddelim
Breast Cancer
Abstract
No successful treatments exist for women with breast cancer that have high levels of the growth factor receptor HER2 and have developed tumors that spread to the brain. This team has developed a mouse model to study breast cancer in the brain. They found a drug that eliminates the visible tumor in the mouse brain, but the tumor eventually grows back. The team will study the changes in the second tumor that show a marker protein that is not seen in the first breast cancer brain tumor. They will test if deleting this marker will restore sensitivity to treatment. They study how the brain tissue supports the breast tumor growth in brain and which signals of the breast cancer cells lead to a tumor friendly environment in the brain. These data will guide better treatment strategies in the future.
Competitiondate
202402
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hombach-Klonisch, Sabine
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $65,000~ $0~